Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option.
Saved in:
| Title: | Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option. |
|---|---|
| Authors: | Narvaez D; Breast Cancer Department, Alexander Fleming Institute, Buenos Aires, Argentina., Parkinson GT; Stanford Healthcare, Stanford, CA, USA., Graff SL; Brown University Health Cancer Institute, Providence, RI, USA; Legorreta Cancer Center at Brown University, Providence, RI, USA. |
| Source: | Chinese clinical oncology [Chin Clin Oncol] 2025 Dec; Vol. 14 (6), pp. 79. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: AME Publishing Company Country of Publication: China NLM ID: 101608375 Publication Model: Print Cited Medium: Internet ISSN: 2304-3873 (Electronic) Linking ISSN: 23043865 NLM ISO Abbreviation: Chin Clin Oncol Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41492871 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Narvaez+D%22">Narvaez D</searchLink>; Breast Cancer Department, Alexander Fleming Institute, Buenos Aires, Argentina.<br /><searchLink fieldCode="AU" term="%22Parkinson+GT%22">Parkinson GT</searchLink>; Stanford Healthcare, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Graff+SL%22">Graff SL</searchLink>; Brown University Health Cancer Institute, Providence, RI, USA; Legorreta Cancer Center at Brown University, Providence, RI, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101608375%22">Chinese clinical oncology</searchLink> [Chin Clin Oncol] 2025 Dec; Vol. 14 (6), pp. 79. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101608375 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2304-3873 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223043865%22">23043865 </searchLink><i>NLM ISO Abbreviation: </i>Chin Clin Oncol <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41492871 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.21037/cco-25-82 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 79 Titles: – TitleFull: Metronomic capecitabine plus aromatase inhibitor as initial therapy in HR-positive HER2-negative metastatic breast cancer: a low-cost and easily implementable option. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Narvaez D – PersonEntity: Name: NameFull: Parkinson GT – PersonEntity: Name: NameFull: Graff SL IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2025 Dec Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2304-3873 Numbering: – Type: volume Value: 14 – Type: issue Value: 6 Titles: – TitleFull: Chinese clinical oncology Type: main |
| ResultId | 1 |
